Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

We are nearing a point of no return for GLP-1 drugs. More than one in 10 Americans have already taken a GLP-1 agonist, be it ...

Experts call for urgent global action on hepatitis, alcohol, and obesity as new data shows that while preventable liver ...